JP2010508328A5 - - Google Patents

Download PDF

Info

Publication number
JP2010508328A5
JP2010508328A5 JP2009535078A JP2009535078A JP2010508328A5 JP 2010508328 A5 JP2010508328 A5 JP 2010508328A5 JP 2009535078 A JP2009535078 A JP 2009535078A JP 2009535078 A JP2009535078 A JP 2009535078A JP 2010508328 A5 JP2010508328 A5 JP 2010508328A5
Authority
JP
Japan
Prior art keywords
trifluoromethyl
phenyl
methyl
pyrazole
tetrahydropyrano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009535078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010508328A (ja
Filing date
Publication date
Priority claimed from GB0621967A external-priority patent/GB0621967D0/en
Priority claimed from GB0717262A external-priority patent/GB0717262D0/en
Application filed filed Critical
Priority claimed from PCT/EP2007/061794 external-priority patent/WO2008053031A1/en
Publication of JP2010508328A publication Critical patent/JP2010508328A/ja
Publication of JP2010508328A5 publication Critical patent/JP2010508328A5/ja
Withdrawn legal-status Critical Current

Links

JP2009535078A 2006-11-03 2007-11-01 Ａｍｐａ受容体を強化する化合物および医薬におけるその使用 Withdrawn JP2010508328A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0621967A GB0621967D0 (en) 2006-11-03 2006-11-03 Compounds
GB0717262A GB0717262D0 (en) 2007-09-05 2007-09-05 Compounds
PCT/EP2007/061794 WO2008053031A1 (en) 2006-11-03 2007-11-01 Compounds which potentiate ampa receptor and uses thereof in medicine

Publications (2)

Publication Number Publication Date
JP2010508328A JP2010508328A (ja) 2010-03-18
JP2010508328A5 true JP2010508328A5 (enExample) 2010-12-24

Family

ID=39099804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535078A Withdrawn JP2010508328A (ja) 2006-11-03 2007-11-01 Ａｍｐａ受容体を強化する化合物および医薬におけるその使用

Country Status (6)

Country Link
US (1) US20100137276A1 (enExample)
EP (1) EP2086643B1 (enExample)
JP (1) JP2010508328A (enExample)
AT (1) ATE502675T1 (enExample)
DE (1) DE602007013450D1 (enExample)
WO (1) WO2008053031A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711089D0 (en) * 2007-06-08 2007-07-18 Glaxo Group Ltd Compounds
GB0711088D0 (en) * 2007-06-08 2007-07-18 Glaxo Group Ltd Compounds
WO2013118845A1 (ja) * 2012-02-08 2013-08-15 武田薬品工業株式会社 複素環化合物およびその用途
AU2016255434C1 (en) 2015-04-29 2021-09-23 Rapport Therapeutics, Inc. Azabenzimidazoles and their use as AMPA receptor modulators
BR112017023200A2 (pt) 2015-04-29 2018-08-07 Janssen Pharmaceutica Nv compostos de indolona e seu uso como moduladores do receptor de ampa
MX373652B (es) 2015-04-29 2020-04-02 Janssen Pharmaceutica Nv Imidazopirazinas y pirazolopirimidinas y su uso como moduladores del receptor de ampa.
WO2016176449A1 (en) 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
GB201702221D0 (en) * 2017-02-10 2017-03-29 Univ Of Sussex Compounds
GB201803340D0 (en) * 2018-03-01 2018-04-18 Univ Of Sussex Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2159479B1 (es) 1999-10-25 2002-05-01 Menarini Lab Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
ATE468326T1 (de) 2004-08-09 2010-06-15 Glaxo Group Ltd Verbindungen zur verstärkung der glutamatrezeptorwirkung und deren verwendung in der medizin

Similar Documents

Publication Publication Date Title
JP2010508328A5 (enExample)
JP6517976B2 (ja) 炎症性障害の治療のための化合物及びその医薬組成物
RU2396269C2 (ru) Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpt1)
HRP20231310T1 (hr) Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
ES2727376T3 (es) Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK
CA2775475C (en) Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
JP2015514783A (ja) ベンゾチアゾール−６−イル酢酸誘導体およびｈｉｖ感染を処置するためのそれらの使用
JP2016512511A5 (enExample)
RU2015129538A (ru) Замещенные имидазопиридины в качестве ингибиторов hdm2
HRP20171670T1 (hr) Spojevi i sastavi za moduliranje egfr-aktiviteta
US9181272B2 (en) Aldosterone synthase inhibitors
RU2012136643A (ru) [5,6]- гетероциклическое соединение
JP2006503010A5 (enExample)
RU2016111675A (ru) Соединения биарилацетамида и способы их применения
JP2015510938A5 (enExample)
NO338017B1 (no) Tiazolderivater, farmasøytiske preparater inneholdende slike, og anvendelse derav
TW201103926A (en) Inhibitors of mTOR and methods of making and using
NZ601656A (en) Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease
JP2014516074A5 (enExample)
WO2013130855A1 (en) Indazole derivatives
SI2790705T1 (en) Use of activity inhibitors or PI3K function
WO2013117645A1 (en) Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
JP2009515814A5 (enExample)
JP2018507235A5 (enExample)
KR20180014433A (ko) 핵 수용체 조절제